OA11094A - Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration - Google Patents
Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration Download PDFInfo
- Publication number
- OA11094A OA11094A OA9800077A OA9800077A OA11094A OA 11094 A OA11094 A OA 11094A OA 9800077 A OA9800077 A OA 9800077A OA 9800077 A OA9800077 A OA 9800077A OA 11094 A OA11094 A OA 11094A
- Authority
- OA
- OAPI
- Prior art keywords
- group
- hydrogen
- process according
- alkyl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9525606.1A GB9525606D0 (en) | 1995-12-14 | 1995-12-14 | Method and compositions for the synthesis of dioxolane nucleosides with - configuration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA11094A true OA11094A (en) | 2003-03-13 |
Family
ID=10785435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA9800077A OA11094A (en) | 1995-12-14 | 1998-06-09 | Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US5922867A (enExample) |
| EP (1) | EP0970074B1 (enExample) |
| JP (1) | JP3229990B2 (enExample) |
| KR (1) | KR100406159B1 (enExample) |
| CN (1) | CN1080263C (enExample) |
| AP (1) | AP879A (enExample) |
| AT (1) | ATE214699T1 (enExample) |
| AU (1) | AU706328B2 (enExample) |
| BR (1) | BR9612351A (enExample) |
| CA (1) | CA2237730C (enExample) |
| DE (1) | DE69620042T2 (enExample) |
| DK (1) | DK0970074T3 (enExample) |
| EA (1) | EA000844B1 (enExample) |
| ES (1) | ES2172697T3 (enExample) |
| GB (1) | GB9525606D0 (enExample) |
| HU (1) | HU224076B1 (enExample) |
| IL (3) | IL124663A (enExample) |
| IN (1) | IN187349B (enExample) |
| MX (1) | MX9804701A (enExample) |
| NO (1) | NO309901B1 (enExample) |
| NZ (1) | NZ323855A (enExample) |
| OA (1) | OA11094A (enExample) |
| PL (1) | PL188447B1 (enExample) |
| PT (1) | PT970074E (enExample) |
| TW (1) | TW341574B (enExample) |
| WO (1) | WO1997021706A1 (enExample) |
| ZA (1) | ZA9610544B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410546B1 (en) | 1997-04-07 | 2002-06-25 | Triangle Pharmaceuticals, Inc. | Use of MKC-442 in combination with other antiviral agents |
| ATE282034T1 (de) | 1998-08-12 | 2004-11-15 | Gilead Sciences Inc | Verfahren zur herstellung von 1,3- oxathiolannukleoside |
| US6979561B1 (en) | 1998-10-09 | 2005-12-27 | Gilead Sciences, Inc. | Non-homogeneous systems for the resolution of enantiomeric mixtures |
| HUP0104827A3 (en) | 1998-12-23 | 2002-08-28 | Shire Biochem Inc Laval | Antiviral nucleoside analogues |
| EP1151133A1 (en) * | 1999-02-11 | 2001-11-07 | McGILL UNIVERSITY | Stereoselective synthesis of nucleoside analogues |
| WO2001022950A2 (en) * | 1999-09-24 | 2001-04-05 | Shire Biochem Inc. | Diosolane nucleoside analogs for the treatment or prevention of viral infection |
| EP1225899A2 (en) * | 1999-11-04 | 2002-07-31 | Virochem Pharma Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
| US7038039B2 (en) * | 2000-02-10 | 2006-05-02 | Mitsui Chemicals, Inc. | Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside |
| JP2003522769A (ja) | 2000-02-11 | 2003-07-29 | シェア バイオケム インコーポレーテッド | ヌクレオシド類似体の立体選択的合成 |
| WO2002051852A1 (fr) * | 2000-12-27 | 2002-07-04 | Mitsui Chemicals, Inc. | Procede de production d'un derive de saccharide non naturel |
| ATE383355T1 (de) | 2001-03-01 | 2008-01-15 | Abbott Lab | Polymorph und andere kristallinische formen von zusammen-ftc |
| WO2003020222A2 (en) * | 2001-09-04 | 2003-03-13 | Merck & Co., Inc. | PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE |
| AU2002336864B2 (en) * | 2001-11-02 | 2006-08-17 | Shire Biochem Inc. | Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs |
| BR0214944A (pt) | 2001-12-14 | 2005-06-07 | Pharmasset Ltd | Nucleosìdeos de n4-acilcitosina para o tratamento de infecções virais |
| EP1467990B1 (en) | 2002-01-25 | 2012-03-07 | Shire BioChem Inc. | Process for producing dioxolane nucleoside analogue precursors |
| IL166682A0 (en) | 2002-08-06 | 2006-01-15 | Pharmasset Ltd | Processes for preparing 1,3-dioxolane nucleosides |
| KR101113341B1 (ko) | 2002-10-15 | 2012-09-27 | 엑손모빌 케미칼 패턴츠 인코포레이티드 | 올레핀 중합용 다중 촉매 시스템 및 이로부터 제조된중합체 |
| DE10335061B4 (de) * | 2003-07-31 | 2005-11-17 | Wacker-Chemie Gmbh | Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten |
| EP1720840B1 (en) * | 2004-02-03 | 2016-02-03 | Emory University | Methods to manufacture 1,3-dioxolane nucleosides |
| US7749531B2 (en) * | 2005-06-08 | 2010-07-06 | Indicator Systems International | Apparatus and method for detecting bacterial growth beneath a wound dressing |
| BRPI0813036A2 (pt) * | 2007-07-30 | 2017-10-24 | Rfs Pharma Llc | processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina. |
| CN101862676B (zh) * | 2009-04-17 | 2012-01-25 | 中国石油化工股份有限公司 | 大孔径sba-15介孔材料-三氟甲磺酸铜复合催化剂、制备方法及应用 |
| CN103288806A (zh) * | 2013-07-02 | 2013-09-11 | 山东大学 | 一种曲沙他滨的合成方法 |
| WO2018022263A1 (en) | 2016-07-29 | 2018-02-01 | Exxonmobil Chemical Patents Inc. | Polymerization processes using high molecular weight polyhydric quenching agents |
| JP7337539B2 (ja) | 2018-06-21 | 2023-09-04 | メディヴィル・アクチエボラーグ | 白血病療法のための塩基修飾シチジンヌクレオチド |
| WO2019245444A1 (en) | 2018-06-21 | 2019-12-26 | Medivir Ab | Base-modified cytidine nucleotides for leukemia therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
| FI932871A7 (fi) * | 1992-06-22 | 1993-12-23 | Lilly Co Eli | Stereoselektiivinen anioniglykosylaatioprosessi |
-
1995
- 1995-12-14 GB GBGB9525606.1A patent/GB9525606D0/en active Pending
-
1996
- 1996-12-13 AU AU10893/97A patent/AU706328B2/en not_active Expired
- 1996-12-13 IL IL12466396A patent/IL124663A/en not_active IP Right Cessation
- 1996-12-13 DE DE69620042T patent/DE69620042T2/de not_active Expired - Lifetime
- 1996-12-13 EP EP96941539A patent/EP0970074B1/en not_active Expired - Lifetime
- 1996-12-13 US US08/849,722 patent/US5922867A/en not_active Expired - Lifetime
- 1996-12-13 PT PT96941539T patent/PT970074E/pt unknown
- 1996-12-13 IL IL14415596A patent/IL144155A/xx not_active IP Right Cessation
- 1996-12-13 AP APAP/P/1998/001252A patent/AP879A/en active
- 1996-12-13 IN IN2810DE1996 patent/IN187349B/en unknown
- 1996-12-13 JP JP52157397A patent/JP3229990B2/ja not_active Expired - Lifetime
- 1996-12-13 PL PL96327443A patent/PL188447B1/pl not_active IP Right Cessation
- 1996-12-13 BR BR9612351A patent/BR9612351A/pt not_active Application Discontinuation
- 1996-12-13 DK DK96941539T patent/DK0970074T3/da active
- 1996-12-13 CN CN96199879A patent/CN1080263C/zh not_active Expired - Lifetime
- 1996-12-13 KR KR10-1998-0704473A patent/KR100406159B1/ko not_active Expired - Fee Related
- 1996-12-13 EA EA199800555A patent/EA000844B1/ru not_active IP Right Cessation
- 1996-12-13 TW TW085115392A patent/TW341574B/zh active
- 1996-12-13 ZA ZA9610544A patent/ZA9610544B/xx unknown
- 1996-12-13 ES ES96941539T patent/ES2172697T3/es not_active Expired - Lifetime
- 1996-12-13 CA CA002237730A patent/CA2237730C/en not_active Expired - Lifetime
- 1996-12-13 HU HU9901050A patent/HU224076B1/hu active IP Right Grant
- 1996-12-13 AT AT96941539T patent/ATE214699T1/de not_active IP Right Cessation
- 1996-12-13 NZ NZ323855A patent/NZ323855A/xx unknown
- 1996-12-13 WO PCT/CA1996/000845 patent/WO1997021706A1/en not_active Ceased
-
1998
- 1998-06-09 OA OA9800077A patent/OA11094A/en unknown
- 1998-06-11 MX MX9804701A patent/MX9804701A/es unknown
- 1998-06-12 NO NO982716A patent/NO309901B1/no unknown
-
1999
- 1999-02-17 US US09/251,431 patent/US6069250A/en not_active Expired - Lifetime
-
2001
- 2001-07-05 IL IL14415501A patent/IL144155A0/xx unknown
- 2001-11-16 US US09/987,845 patent/US20020058670A1/en not_active Abandoned
-
2002
- 2002-10-02 US US10/262,107 patent/US20030060476A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA11094A (en) | Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration | |
| KR0160144B1 (ko) | 뉴클레오시드의 부분 입체 이성체를 선택적으로 합성하는 방법 | |
| FI112078B (fi) | Nukleosidianalogien stereoselektiivinen synteesi kaksirenkaista välituotetta käyttämällä | |
| KR101108115B1 (ko) | 1,3-디옥솔란 뉴클레오사이드의 제조 방법 | |
| EP1632490A1 (en) | Stereoselective method for the preparation of nucleoside analogues | |
| HK1017886B (en) | METHOD AND INTERMEDIATE FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDE WITH β-CONFIGURATION | |
| CN1222157A (zh) | 高收率非对映选择性合成二脱氧核苷的方法 | |
| HK1008673B (en) | Stereoselective synthesis of nucleoside analogues using bicyclic intermediate |